Ignite Creation Date:
2024-05-06 @ 12:42 PM
Last Modification Date:
2024-10-26 @ 1:02 PM
Study NCT ID:
NCT03820830
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2019-01-25
Brief Title:
Palbociclib for HR Positive HER2-negative Isolated Locoregional Recurrence of Breast Cancer
Sponsor:
Organization:
ETOP IBCSG Partners Foundation